Induction and function of virus-specific CD4+ T cell responses  by Whitmire, Jason K.
Virology 411 (2011) 216–228
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roReview
Induction and function of virus-speciﬁc CD4+ T cell responses
Jason K. Whitmire ⁎
Carolina Vaccine Institute, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA⁎ UNC-Chapel Hill, CB#7292, 9024 Burnett Womack, 1
NC 27599, USA. Fax: +1 919 843 6924.
E-mail address: jwhitmir@email.unc.edu.
0042-6822/$ – see front matter © 2010 Elsevier Inc. Al
doi:10.1016/j.virol.2010.12.015a b s t r a c ta r t i c l e i n f oArticle history:
Received 7 December 2010
Accepted 8 December 2010
Available online 14 January 2011
Keywords:
Virus infection




B cellsCD4+ T cells – often referred to as T-helper cells – play a central role in immune defense and pathogenesis.
Virus infections and vaccines stimulate and expand populations of antigen-speciﬁc CD4+ T cells in mice and
in man. These virus-speciﬁc CD4+ T cells are extremely important in antiviral protection: deﬁciencies in
CD4+ T cells are associated with virus reactivation, generalized susceptibility to opportunistic infections, and
poor vaccine efﬁcacy. As described below, CD4+ T cells inﬂuence effector andmemory CD8+ T cell responses,
humoral immunity, and the antimicrobial activity of macrophages and are involved in recruiting cells to sites
of infection. This review summarizes a few key points about the dynamics of the CD4+ T cell response to virus
infection, the positive role of pro-inﬂammatory cytokines in the differentiation of virus-speciﬁc CD4+ T cells,
and new areas of investigation to improve vaccines against virus infection.01 Manning Drive, Chapel Hill,
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Viruses and the immune system are linked: viruses infect and
replicate in an environment where cells are devoted to destroying the
infection, so viruses have evolved mechanisms to elude the immune
response; conversely, viruses have impacted the survival of their
hosts, so the genomes of survivors are imprinted by past battles.Viruses and the immune system change in real time during an
infection with detectable heritable changes in the viral genome and
the selective expansion and differentiation of T cells and B cells with
epigenetic changes that carry on for the life of the animal. The study of
how the immune system copes with virus infection is a key to
understanding virus replication strategies and their overall structure,
why certain populations of cells are targeted for infection, and the
selection of virus mutants with growth advantage. Likewise, one can
decipher how the immune system functions by studying how viruses
evolve to survive and propagate in hosts.
CD4+ T cells impact antiviral immunity at multiple stages of the
immune response. CD4+ T cells inﬂuence antiviral cellular and humoral
Fig. 2. The T cell response following acute LCMV infection in mice. The T cell response
following acute LCMV infection provides a well-deﬁned model to study how CD4+ T
cells, CD8+ T cells, and B cell responses develop. The graph shows the dramatic
increase in the number of virus-speciﬁc T cells after infection and the establishment of
elevated numbers of memory T cells. The innate immune response begins immediately
after infection and affects the subsequent T cell response. Responding T cells produce
interferon-gamma and express other molecules that impact their expansion in number
and differentiation into memory cells. The essential patterns are shown for a robust
acute infection, but other infections show smaller or delayed responses that are related
to differences in the magnitude or duration of infection and variations in the
inﬂammatory environment.
217J.K. Whitmire / Virology 411 (2011) 216–228immunity and play a direct role in suppressing virus infection (Fig. 1). As
discussed below, CD4+ T cells enhance early expansion of virus-speciﬁc
primary CTL, their subsequent differentiation into memory cells, guide
their localization to sites of infection, and drive secondary expansion of
memoryCD8+Tcells during re-infection. CD4+Tcells are critical for the
processes that lead to long-termhumoral immunity, which is the basis of
protection for many infections and vaccines. People with deﬁciencies in
CD4+ T cell responses or who havemutations in themolecules involved
in CD4–B cell interactions show severe defects in cellular and humoral
immunity and suffer from recurrent opportunistic infections. Antiviral
CD4+ T cells may interact directly with eosinophils and impact their
recruitment and function in lung tissues, potentially contributing to the
pathogenesis seen after some lung infections. Thus, virus-speciﬁc
CD4+ T cells form the nexus between immunologic protection and
immune-mediated pathogenesis following infection, so a deep under-
standing of their induction, regulation, and function is needed to develop
safe and effective vaccines against ongoing viral threats. Amajor point in
this review is that CD4+Tcell differentiation andactivity is controlled by
where they reside.
TheT cell response followingvirus infection consists of several stages
(Fig. 2). Innate inﬂammatory processes begin immediately after
infection and are largely driven by various pattern recognition
receptors, including toll-like receptors (TLR) that recognize viral
material at the cell surface or within the endocytic compartment, and
RIG-I-like receptors (RLR) and nucleotide-binding domain-leucine-rich
repeat-containing molecules (NLR) that recognize viral material in the
cytoplasm. These signals induce type 1 interferon production and other
pro-inﬂammatory cytokines; a cascadeof signalingevents occurs in cells
anywhere near the source of IFN. Interferon stimulated cells are induced
to express new proteins that have antiviral activities, including ISG15,
ISG20, RNAse-L, protein kinase R (PKR), 2′,5′oligoadenylate synthetases,
Mx1, TRIM5α, and others (Borrow et al., 2010;Wilkins and Gale, 2010).
The effect of IFN can vary by cell type. Besides direct antiviral effects, IFN
transiently retains cells in lymphoid tissue by stimulating CD69
expression, which blocks the activity of sphingosine 1-phosphate
receptor-1 (Shiow et al., 2006). IFN acts to enhance MHC presentation
of antigens to T cells andmodiﬁes the proteolyticmachinery involved in
producing the peptides thatwill be recognized by T cells. IFNs stimulate
APCs to express costimulatory molecules, potentiating the adaptiveFig. 1. The central role of virus-speciﬁc CD4 T cells in immune defense. Antiviral CD4+ T cell
interact directly with antigen presenting cells to enhance their ability to present viral anti
and plasma cells and affect the kind of antibody that is made. CD4+ T cells can directly supp
CD8+ T cell responses to many infections and enhance the protective recall response of mT cell response. During this early time, NK cells become activated and
release interferon-gamma. The rapid detection of virus material and
production of IFNs serves to diminish virus replication and alert the
immune system to infection. Within a few hours after infection, viral
antigen is presented to T cells and a few days later, there is an explosive
expansion of antiviral T cells (Whitmire et al., 2006, 2008b). It starts
from a minute population of cells that begin dividing at incredibly fast
rates with the population doubling at a rate on the order of once per
4–5 h, and the respondingcells increase innumberexponentiallyduring
this time (Whitmire et al., 2006). Impressively, as the cells accumulate,
they also differentiate into different lineages and transition into
memory cells, carryout their direct antiviral functions, travel throughout
the body, and assist otherwings of the immune system (Whitmire et al.,
2006). These events unfold in an inﬂammatory environment that guides
T cell differentiation and is in turn impacted by their presence. The
outcomeof this complex network of interactions is initially an expandeds affect multiple wings of the immune system to protect against infection. CD4+ T cells
gen to T cells. They engage B cells and direct their differentiation into memory B cells
ress virus infection in MHCII+ target cells. CD4+ T cells are essential to induce antiviral
emory CD8+ T cells.
218 J.K. Whitmire / Virology 411 (2011) 216–228population of short-lived virus-reactive T cells, some of which further
differentiate and transition into quiescent memory cells, which confer
expedited immunity over extended periods of time. A key point is that
innate and adaptive immunity are linked: early inﬂammatory pathways
have an immediate impact in limiting infection and a long-term impact
on T cell memory, inﬂuencing the kind and number of memory cell that
survives and the kind of recall response that develops upon re-infection.
The T cell response following virus infection typically consists of 2
major populations of cells: virus-speciﬁc CD8+ T cells and CD4+
T cells
Antiviral CD8+ T cells and CD4+ T cell responses begin from a
small number of naïve precursor cells that expand in a non-linear way
with roughly similar kinetics of induction and cell-division rate
(Whitmire et al., 2006, 2008b). There are a number of differences
between CD8+ T cells and CD4+ T cells, which should be considered
in order to understand why and how viruses avoid them.
Virus-speciﬁc CD8+ T cells and CD4+ T cells recognize different
aspects of infection and carryout distinct functions. CD4+ T cells
recognize viral antigen that is presented by MHCII molecules on a
limited number of cells: dendritic cells (DC), B cells, and monocytes/
macrophages. CD4+ T cells “see” fragments of extracellular material
that professional antigen presenting cells (APC) have taken up,
degraded, and presented in the context of MHCII. DCs efﬁciently take-
up antigen in the periphery, then travel to the draining lymph nodes,
where they process and present antigen to T cells. The separation
between scavenging for foreign material and the presentation of that
material at different sites is seen for inert antigens, but may or may not
hold following live virus infections where there is active recruitment of
activated APCs to the site of infection. As discussed below, CD4+ T cells
can engage these cells out in peripheral sites and impact their behavior
or localization. The extracellularmaterial can includeviral particles, viral
proteins, and viral debris fromnecrotic cells. In contrast to CD4+T cells,
CD8+ T cells recognize MHC1 molecules that are loaded with peptides
derived from intracellularproteins; theseproteins areubiquitinatedand
degraded by the proteasome or immunoproteasome into peptides that
are shuttled into the secretory pathway, where they are loaded onto
MHC1 molecules. The epitopes that are presented on MHC1 molecules
are largely derived from viral protein that has entered the cytosol as a
result of infection (fusion) or from proteins arising from the de novo
synthesis of viral protein fromviral nucleic acid sequences. CD8+T cells
can be stimulated by extracellular protein through a process termed
“cross-presentation”, but the protective value of this presentation, and
the extent to which cross-presentation happens during the course of a
natural infection is not clear and could be somewhat less efﬁcient
compared with endogenous “classical” pathways of antigen presenta-
tion; a recent study of vaccinia virus infection found that direct
presentation, and not cross-presentation, plays the major role in the
induction of antiviral CD8+ T cells (Xu et al., 2010). There are several
recent reviews of cross-presentation (Bevan, 2006; Blanchard and
Shastri, 2010; Rock et al., 2010; Yewdell, 2010; Yewdell and Haeryfar,
2005).
CD4+ T cells can be induced by cells that are not actually infected
and recognize antigen from non-replicating virusmaterial, so they can
be far more sensitive to foreign antigen than CD8+ T cells. For
example, non-replicating or inactivated vaccines composed of viral
proteins or bacterial toxins induce CD4+ T cell responses but
negligible CD8+ T cell responses. Many viruses effectively inhibit
antigen-presentation to CD8+ T cells, but such blockade does not
affect CD4+ T cells, since non-infected cells still efﬁciently take up
and present antigen. An example of this effect is seen following
Coxsackie virus infection of mice; certain viral proteins (2B, 2BC, 3A)
prevent the surface expression of MHC1 (Cornell et al., 2006, 2007).
Minimal to no detectable CD8 response is induced in these mice, even
when using extremely sensitive techniques; in contrast, CVB3-speciﬁcCD4+ T cells are stimulated and readily measured (Kemball et al.,
2008, 2009). Other viruses, such as the myxoma virus (Zuniga
et al., 1999), adenovirus (Blair and Blair-Zajdel, 2004;Windheim et al.,
2004), HSV (Ahn et al., 1996; Barcy and Corey, 2001; Neumann et al.,
2003; Orr et al., 2005; Sievers et al., 2002; Temme et al., 2010),
Varicella-zoster virus (Eisfeld et al., 2007), MCMV (del Val et al., 1992;
Heise et al., 1998; Lemmermann et al., 2010), and HCMV (Jackson et
al., in press), also have elaborate mechanisms to prevent MHC antigen
presentation, thus reducing their visibility to the immune system. It is
intrinsically difﬁcult for viruses to dodge CD4+ T cell responses, but
several major mechanisms have been identiﬁed, including the
production of viral homologs of IL-10 (EBV, MCMV) (Kanai et al.,
2007; Knappe et al., 2000; Kotenko et al., 2000) to generally suppress
MHC expression, targeting DC for depletion by CD8+ T cells (Zuniga
et al., 2008), and down-regulating MHCII expression on infected cells
(Hegde et al., 2002; Lewandowski et al., 1993).
Another key difference between virus-speciﬁc CD8+ T cells and
CD4+ T cells is the efﬁciency with which they kill target cells: this is
done expeditiously by antigen-experienced CD8+ T cells, whereas
such killing by CD4+ T cells is sluggish. This can be demonstrated
using an “in vivo CTL assay”. In this assay, target cells are loaded with
speciﬁc or irrelevant peptides and then differentially labeled with a
dye (CFSE) and intravenously transferred into the same host; after a
short period of time, ﬂow cytometry is used to compare the relative
loss of the speciﬁc peptide-coated cells compared to the control target
cells. When target cells are loaded with an LCMV peptide that binds
MHCI and is recognized by immunodominant LCMV-speciﬁc CD8+ T
cells, they are completely eliminated within minutes upon transfer
into an LCMV-immune mouse. By comparison, only a small fraction of
GP61–80-loaded target cells are killed in these mice over a time span of
one day. Thus cytolytic CD4+ T cells emerge after infection (Jellison et
al., 2005), but their protective role based on direct killing of target cells
after infection pales in comparison with virus-speciﬁc CD8+ T cells
that kill within minutes (Yates et al., 2007). This is underscored by the
inability of CD8-deﬁcient mice to resolve LCMV infection despite the
presence of large numbers of virus-speciﬁc CD4+ T cells. The
mechanisms of killing are also very different: CD8+ CTL rely upon
preformed perforin and granzyme molecules to poke holes into the
target cells; CD4+ T cells utilize FAS-L and TRAIL to induce a caspase-
dependent apoptosis. The dichotomy in rapid killing ability makes
sense given that cytolytic cells are restricted to targets that are actually
infected as opposed to nearby antigen presenting cells that have taken
up antigen and are involved in alerting the immune system to
infection. Such restricted killing may be beneﬁcial by preserving APC
whose depletion would cause generalized immune incompetence. An
example of the detrimental effects of APC loss are seen following
infection of mice with LCMV variants that selectively infect DC; the
resulting CTL response eliminates these cells and the mice become
susceptible to other infections (Sevilla et al., 2000, 2003; Zuniga et al.,
2008). Similar pathogenesis may occur in people exposed to inﬂuenza,
who then acquire lethal bacterial infections. Virus-speciﬁc CD4+ and
CD8+ T cells share the ability to directly suppress virus replication by
bathing target cells in IFNγ, but CD4+ T cells accomplish this without
the collateral damage caused by perforin-dependent cell killing.
CD4+ T cells help CD8+ T cell-dependent antiviral defenses
Formany virus infections CD4+T cells are needed to drive the initial
expansion of virus-speciﬁc CD8+T cells (Williams and Bevan, 2007). In
the absence of CD4+ T cells there is minimal expansion of CD8+ T cells
and deﬁcient cellular immunity. Virus-speciﬁc CD4+T cells engage DCs
that are shared with reactive CD8+ T cells; the CD4+ T cells stimulate
the APCs to express costimulatory molecules and to increase the
presentation of viral antigen so that the APCs better stimulate CD8+
T cells. CD4+ T cells are efﬁcient producers of IL-2, which is a growth
factor for CD8+ T cells and encourages improved cell-division and cell
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(and IFNγ, see below) acts on nearby virus-speciﬁc CD8+ T cells. Such
interactionsmight occurwhen both cells are adjacent to a virus infected
APC.
Many virus infections grow to high titer in vivo and, due to efﬁcient
MHCI presentation, readily stimulate virus-speciﬁc CD8+ T cells.
Virus-speciﬁc CD4+ T cells often are not needed for the initial
expansion of CD8+ T cells in these models. However, CD4+ T cells
affect the subsequent ability of memory CD8+ T cells to undergo
vigorous secondary responses upon re-challenge with infection
(Hamilton et al., 2006; Janssen et al., 2003; Shedlock and Shen,
2003; Sun and Bevan, 2003; Sun et al., 2004). Evidence indicates that
early CD4-dependent signals leave a lasting effect on memory cell
formation; help-less CD8 T cells expand poorly compared to those that
differentiate in the presence of CD4+ T cells. Other evidence
implicates memory CD4+ T cell effects during the actual recall
response itself (Agnellini et al., 2008). In this case, CD4+T cells deliver
signals – and it is not clear what they are – that further the ability of
respondingmemory CD8+T cells to accumulate in number (Sun et al.,
2004). The simultaneous activation of memory CD4+ T cells and
memory CD8+ T cells results in a more protective CTL response
compared to the activation of CD8+ T cells alone.
Antiviral T cells circulatewidely after infection (Marshall et al., 2001;
Masopust et al., 2001; Whitmire et al., 2006). In several model systems,
antiviral CD4+ T cells are needed to recruit CD8+ T cells and other cell
types to peripheral sites of infection. For example, CD4+ T cells recruit
mouse hepatitis virus-speciﬁc CD8+ T cells into the CNS (Stohlman et
al., 1998). CD4+ T cells recruit inﬂuenza-speciﬁc CD8+ T cells into the
lung (Teijaro et al., 2010). HSV2-speciﬁc CD4+ T cells enhance CD8+
T cell movement to HSV2 infected tissues, and the effect is dependent
upon IFNγ production by the CD4+ T cells and the local induction of
CXCR3 that allows circulating CD8+ T cells to enter the tissue
(Nakanishi et al., 2009). Perhaps the local production of IFNαβ caused
by infection results in an inﬂux of cells, including those with antigen
presenting functions and CD4+ T cells. Once there, CD4+ T cells direct
other responses locally andguide other cell types into the infected tissue
(Lane et al., 2000).
Virus-speciﬁc CD4+ T cells sustain antiviral CD8+ T cell responses
during protracted infections (Khanolkar et al., 2004; Kumaraguru et al.,
2005; Wherry et al., 2007; Zajac et al., 1998a). For example, variants of
LCMV will grow to high titer and target new populations of cells and
disseminate throughout the body of the mouse. The CD8+ T cell
response against these variants is strained and eventually virus-speciﬁc
CD8+ T cells either undergo apoptosis or become dysfunctional
(exhausted), losing their ability to proliferate and produce cytokines
when exposed to their cognate antigen. Eventually, wildtype mice
reduce the viral load to levels at or below the detection limits of plaque
assay in most tissues but not mice that are depleted of CD4+ T cells
(Battegay et al., 1994; Leist et al., 1989; Matloubian et al., 1994).
Transient depletion of CD4+ T cells is sufﬁcient to prevent long-term
control of these variants. In wildtype mice, functional cytolytic CD8+
T cells can be recovered once the infection is controlled, but in
CD4-deﬁcient mice, functional CD8+ T cells are not recovered.
Dysfunctional CD8+ T cells can be rescued by the adoptive transfer of
functional CD4+T cells (Homann et al., 1998; Kumaraguru et al., 2005).
The mechanism by which CD4+ T cells rescue virus-speciﬁc CD8+
T cells is elusive; it could be related to the release of copious amounts of
IL-2 that acts on CD8+ T cells, the ability of CD4+ T cells to stimulate
APC activity or survival that indirectly sustains CD8+T cells, or possibly
modulation of inhibitory receptor–ligand interactions between CD8+
T cells and APCs. Virus-speciﬁc CD4+ T cell production of IL-21 sustains
antiviral CD8+ T cells during persistent virus infection (Elsaesser et al.,
2009; Frohlich et al., 2009; Melief and Schoenberger, 2010; Yi et al.,
2009, 2010). CD4+ T cells may also protect APCs from CTL-mediated
killing (Mueller et al., 2006), thus preserving their immune-stimulatory
functions.Big responses from small numbers
The T cell Receptor consists of several subunits, and the regions
involved in bindingpeptide andMHCcomplexes are highly variable and
lead to a diverse array of pro-T cells that travel from the bonemarrow to
the thymus; a subset of the cells goon todifferentiate into single positive
CD4+ or CD8+ T cells that populate the peripheral lymphoid organs.
Based on the number of domains, their random juxtaposition and
additional sequences that are added at the joining sites, the theoretical
variety of unique TCRs is enormous and far greater than the actual
number of cells in a mouse. Until recently, the frequency of any given
antigen-speciﬁc T cell in the naïve pool was unknown, but it was
estimated by CDR3-length measurements of different classes of TCR
molecules that there are approximately 2×106 distinct T cell precursor
pools, each containing an average of 10 cells (Casrouge et al., 2000). This
estimate was largely borne-out by direct measurements of antigen-
speciﬁc cells using either functional methods or tetramer-enrichment
techniques. For example, in an uninfected wildtype (B6) mouse, there
are approximately 100 CD4+T cells with the potential to respond to an
immuno-dominant I-Ab-restricted epitope of LCMV (GP61–80)
(MacLeod et al., 2008; Whitmire et al., 2006). A similar frequency for
an immuno-dominant LCMV-speciﬁc CD8+T cell population (Blattman
et al., 2002) indicates that there is overlap in the frequencies of
precursors between immuno-dominant CD4+ and CD8+ T cells. The
frequency for other epitope-speciﬁc T cell precursors ranges from
~10–1000 permouse (Hataye et al., 2006;Moon et al., 2007; Obar et al.,
2008). There is a trend where the initial naïve precursor frequency
correlates with the subsequent immunodominance hierarchy that is
seen following infection, but this pattern does not always hold.
The induction phase of the response commences immediately
upon infection and involves viral antigen along with inﬂammatory
signals and costimulatory signals. Within a few hours after infection,
viral antigen is presented to T cells at sufﬁcient levels to stimulate
antigen-experienced cells to make cytokine (Whitmire et al., 2008b).
This can be shown experimentally by re-challenging immune mice,
which contain large numbers of memory T cells, and then directly
injecting BFA soon afterwards. The BFA acts to prevent T cell secretion
of IFNγ, so reactive cells accumulate this cytokine following antigen
exposure in vivo. The cells are isolated and immediately stained for
intracellular IFNγ without further ex-vivo manipulation. A large
fraction of virus-speciﬁc CD4+ T cells will express IFNγ 6–12 h after
infection, indicating that those cells recognized their cognate antigen
in vivo. The actual speed with which antigen is presented may be
much faster and on a timescale of minutes. From the standpoint of
virus infection, it is important to have an adaptive response that
matches the rate at which viruses replicate and spread. These events
can happen quickly (such as LCMV replication and spread in mice)
and the T cell response occurs quickly; other infections are slow and
the resulting T cell response dithers. For example, the T cell responses
against mycobacteria peak one month after infection; the T cell
responses against the hepatotropic viruses HAV and HCV only emerge
4–6 weeks after infection. It is unclear why the kinetics vary so
dramatically—different viruses and other pathogens inﬂuence the
kind of milieu that forms during these critical stages of the T cell
response, and this may explain the variation in kinetics, quality and
magnitude of subsequent memory T cells. It is also possible that some
viruses have evolved mechanisms to delay the kinetics to facilitate
virus survival and spread. For example, the liver environment
suppresses immune responses, which may explain why viruses
targeting that location induce small and delayed immune responses.
Despite the initial presence of LCMVantigen, virus-speciﬁc naïve and
memory T cells undergo cell division after a delay of up to 3 days,
followed by an explosive transition into extremely rapid cell division
and accumulation (Whitmire et al., 2008b). The initiation of the
response is governed, at least in part, by the inﬂammatory environment
as opposed to intrinsic limits governing the ability of T cells to transform
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are placed within an inﬂamed environment (i.e. a pre-infected mouse)
are able to begin dividing without much delay (2 days as opposed to
3–4 days), which implies that certain signals beyond antigen, are
involved in initiating the rapid response. These signals could include the
induction of positive regulators or the elimination of negative regulators
or Treg cells.
As the response develops, populations of cells are differentially
impacted by various selective forces – including antigen abundance,
TCR-peptide/MHC afﬁnity, and cytokines – that determine the cells
that preferentially grow out in number and contribute to T cell
differentiation and survival into the memory phase. The magnitude of
the CD4 response is largely governed by the amount and duration of
the antigen (Obst et al., 2005; Ravkov and Williams, 2009). The CD4
response truncateswhen infection is artiﬁcially terminated, such as by
treating recombinant-Listeria monocytogenes-infected mice with
antibiotics. Similar ﬁndings were seen following recall responses.
These analyseswere done in the context of LM-driven T cell responses;
whether similar correlations hold for virus infection remains to be
shown. Analogous experiments using ribavirin in virus infected mice
should be done to evaluate whether antiviral CD4+ T cell responses
are also highly dependent on antigen-dose and duration.
Remarkably, much of the virus-speciﬁc CD4+ T cell accumulation
occurs within a few days, implying cell-division rates on the order of
one population doubling every 4–5 h, but possibly faster if some of the
daughter cells undergo apoptosis during the response. Given the
speed with which viruses replicate, it is important to have an adaptive
immune system that can keep up; on the other hand, a robust
autoreactive response or one that is otherwise misdirected could lead
to catastrophic immune-mediated pathology. Therefore, the response
is heavily governed, but the details of how this occurs are obscure.
Virus infections stimulate distinct lineages of CD4+ T cells that
serve unique functions
As antigen-speciﬁc CD4+ T cells respond to infection, they
differentiate into lineages and produce characteristic sets of cytokines
that impact how they inﬂuence other components of the immune
response. They also express certain chemokine receptors that govern
whether they travel to peripheral sites, localize within lymphoid
organs in T cell zones, or localize near B cell zones. The overall kinetics
of the CD4+ T cell response and their survival/maintenance into the
memory phase has been studied in models that induce predominantly
a Th1-type response. Antiviral Th1 cells are commonly found after live
virus infections, because target cells typically produce IFNαβ, and DC
and NK cells produce IL-12, IL-18 and IFNγ that stimulate cells to
differentiate into the Th1 path. Th1 cells are located in lymphoid
organs but also travel to peripheral sites. They express IFNγ, which
acts on target cells to directly suppress virus replication and augments
antigen presentation by DC, B cells, and macrophages. Th1 cells also
make IL-2 to support the expansion of other responding T cells. Th1
cells in the periphery produce IFNγ that modulates chemokine
gradients and causes macrophages and CD8+ T cells to be recruited
to the sites of infection.
Virus-speciﬁc TFH cells emerge after infection (Johnston et al., 2009;
Yusuf et al., 2010). TFH cells preferentially localize to the B cell
boundaries within lymph nodes rather than circulate to peripheral sites
(McHeyzer-Williams and McHeyzer-Williams, 2004). Given their
proximal location to B cell areas, it is thought that TFH cells are directly
involved in B cell differentiation, including the germinal center response
and memory B cell formation (McHeyzer-Williams et al., 2009). These
CD4+ T cells express CD40L and SAP that are vital for stimulating virus-
speciﬁc B cells to further differentiate into MBC or plasma cells (Crotty
et al., 2003; McHeyzer-Williams and McHeyzer-Williams, 2004). Virus-
speciﬁc TFH cells express IL-4 (a B cell growth factor and differentiation
factor), IFNγ (also a B cell differentiation factor), and CD40L. The ability ofTFH cells to simultaneouslymake IFNγ and IL-4may explainwhy IgG1 and
IgG2aantibodies areoften found together after infection.Many interesting
questions remain about this population of cells: are they short-lived or
long-lived; do they form memory; how are they related to other
populations of virus-speciﬁc CD4+ T cells.
The patterns and behaviors of the other lineages may be similar or
different to Th1 cells, so comparable analyses in other infection models
would be useful, as they would provide insights about adjuvant design
and overall regulation of immunity and immune-mediated pathogen-
esis. For example, virus-speciﬁc Th2 cells are found after some
infections. RSV in particular induces a Th2 response that is associated
with pathogenesis and an excessive inﬂux of eosinophils into the lung.
Virus-speciﬁc Th17, Th21, Th9, and TReg emerge after virus infections, but
much remains to be learned about their regulation, function, and
longevity. Virus-speciﬁc cytotoxic CD4+ T cells are found during some
virus infections (HCMV, MCMV, others) (Appay et al., 2002). Cytotoxic
CD4+T cells express IFNγ and granzyme and FasL could be regarded as
a subset of Th1 cells, but it is possible that they are a unique lineage, and
their relationship to other cells is not clear. These cells hold potential for
therapeutic applications: when primed and expanded artiﬁcially, they
can be adoptively transferred into people with certain tumors to kill
transformed cells.
It is important to consider that live virus infections create unique
milieus that result in complex mixtures of responses, so in an
individual there can be a mixture of CD4+ T cells from different
lineages (Marzo et al., 2002; Roman et al., 2002). CD4+ T cells tend to
fall neatly into distinct lineages, but recent data suggest there is
pliability: Th2 cells can be “re-programmed” into Th1when exposed to
the interferons that are expressed during virus infection (Hegazy et al.,
2010); other data indicate that IFNγ – the proto-typical Th1-inducing
cytokine – is also important for Th2 cell formation (Bocek et al., 2004).
The environment in which the virus grows changes with time, so it is
plausible that CD4differentiation isﬂexible and varies according to the
local abundances of cytokines and antigen that occur throughout the
response.
Memory T cells are a ﬁrst line of defense against re-infection
CD4 T cell memory is typically seen after infection or vaccination
and, where examined, it is long-lived. There are some examples of
memorywaning over time (Homann et al., 2001), but other data show
fairly stable levels over time (Hammarlund et al., 2003; Harrington et
al., 2002; Varga and Welsh, 1998; Whitmire et al., 1998). Evidence
from studies utilizing “marked effector cells” indicate that memory T
cells are derived from antigen-experienced effector cells in a linear
differentiation process from naïve to effector to memory cell
(Harrington et al., 2008; Hu et al., 2001; Jacob and Baltimore, 1999;
Opferman et al., 1999). These studies used transgenic T cells that
contain an inactive marker, which recombines when the T cells are
stimulated by antigen; those T cells and all of their progeny can be
identiﬁed by ﬂow cytometry. Several studies using this approach
show that memory cells that form after infection are marked,
indicating a direct relationship between the effector cells andmemory
cells.
Memory precursors can be identiﬁed early on based on their
expression of IL-7R and their ability to bind tetramers (Kaech et al.,
2003; Kondrack et al., 2003; Lenz et al., 2004; Li et al., 2003; Seddon et
al., 2003).During the initial responsememoryprecursors emerge.Virus-
speciﬁc CD4+ T cells down-regulate IL-7R, but there are cells that re-
express IL-7R (Kaech et al., 2003; Kondrack et al., 2003; Lenz et al., 2004;
Li et al., 2003; Seddon et al., 2003) and down-regulate KLRG1 (Hand et
al., 2007; Joshi et al., 2007). After the infection is resolved, the swollen
number of effector cells is no longer needed and it is energetically
expensive to sustain such a vast population of cells. Therefore, most of
the cells (~90%) are purged during the contraction phase and the
survivors have the characteristics of memory cells (described below).
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accumulates (or at least doesn't die); over time, only IL-7R+ cells
remain and they behave likememory cells. The increased proportion of
IL-7R+cells that is seenduring the contractionphase could either be the
result of deletion of IL-7R- cells, an intrinsic change in cells from
IL-7R− to IL-7R+, or a combination of IL-7R+ cell division and
accumulation along with the loss of IL-7R− cells; there is evidence
consistent with all of these scenarios. The purging process is enigmatic
because cell selection and survival into thememory phase occurs in the
apparent absence of virus replication and inﬂammation. Most evidence
indicates that the virus-speciﬁc T cells undergo caspase-dependent
apoptosis, and the survivingT cells tend to express increased amounts of
Bcl2, Bcl-xL, and Bcl6 (Grayson et al., 2000, 2006; Homann et al., 2001;
Pipkin et al., 2010) compared to effector cells.
Once established, CD4 T cell memory does not require antigen
(Swain et al., 1999) but depends upon cytokines derived from stromal
cells. Antiviral CD4+ T cells use IL-7 and, to a lower extent, IL-15 for
homeostatic maintenance (Jaleco et al., 2003; Lenz et al., 2004; Purton
et al., 2007). In the absence of these cytokines, virus-speciﬁc CD4+ T
cells decline in number; conversely, their number can be increased
above normal when recombinant versions of these cytokines are
given tomice (Boyman et al., 2006b, 2008; Cho et al., 2007; Rubinstein
et al., 2006).
Quiescent memory T cells are responsible for the expedited
immunologic protection seen after immunization. As described
below, naïve and memory cells differ dramatically in frequency,
sensitivity to antigen, cytokine output, and location, which explain
why memory cells confer enhanced immunity compared to naïve
cells.
Frequency
Immune mice mount recall responses that are detectable sooner
than primary responses. The accelerated appearance of the recall
response can be explained by the differences in frequency between
virus-speciﬁc naïve cells (~100 per mouse) that are well below
detection by standard assays versus memory cells that can be
500–1000-fold more abundant. Upon challenge, the naïve cells need
to undergo far more rounds of cell division and accumulation before
they are detected; memory T cells only need to go through a few
rounds; hence, memory responses appear sooner. Most analyses of
memory T cells have been done in immune mice, and the results from
these mice were compared to those from naive mice. However, there
are numerous differences between these two groups ofmice, including
the virus-speciﬁc T cell frequency and the presence of virus-speciﬁc
antibody and CTL that affect antigen load and APC function. To
investigate whether the differentiation changes that occur during the
transition of effector cells into memory cells result in quicker cell
division rates, LCMV-speciﬁc T cells were transferred into naïve mice
that were subsequently infected (Whitmire et al., 2008b) and were
allowed to differentiate into memory T cells. These memory T cells
were isolated, mixed with naïve cells, labeled with CFSE, and
adoptively transferred into the same naïve host. Upon infection, the
two donor populations were identiﬁed by ﬂow cytometry. The data
indicate that when compared in the same host and at similar
frequencies, memory T cells and naïve T cells begin cell-division at
around the same time (Whitmire et al., 2008b).
The recall response mediated by memory T cells is typically more
robust than the primary response. Once naïve and memory T cells
begin dividing, the effector cells derived from the memory T cells
accumulate more efﬁciently than the primary effector cells (MacLeod
et al., 2008; Whitmire et al., 2008b). As a result, there is a rapid rise in
the number of secondary effectors. The rapid accumulation ofmemory
cells compared to their naïve counterparts may relate to the efﬁciency
with which memory cells produce cytokines (IFNγ, IL-2) that increase
cell division or prevent apoptosis; however, the accumulation could bethe result of other epigenetic changes (intrinsically elevated Bcl2
levels). Theremay also be reﬁnement of virus-speciﬁc cells so that only
the best responders are selected to survive into the memory phase;
these cellsmay have slight alterations in TCR structure thatmake them
better able to respond compared to the mixed population of naïve
T cells that react to the same epitope (Williams et al., 2008). Other
genomic changes may be at play in enhancing the responsiveness of
memory cells following infection, including their increased frequency
in peripheral tissues (Klonowski et al., 2004; Lefrancois, 2006).
Sensitivity to antigen
Compared to naïve cells, memory T cells are 50–500-fold more
sensitive to antigen (Slifka and Whitton, 2001; Whitmire et al., 2006;
Williams et al., 2008). The improvement in sensitivity to low quantities
of antigen occurs during the expansion phase and carries on into
memory. The molecular mechanisms that permit greater sensitivity
have not been worked out: there may be differences in TCR abundance,
preformed signaling components associated with the TCR, or increased
levels of accessorymolecules that improve T cell associationwith target
cells. For example, memory cells express pre-formed costimulatory
molecules that can immediately be secreted to the surface of cells to
engage APCs (Koguchi et al., 2007).
Effector functions
A major difference between memory T cells and naïve T cells is
their ability to rapidly make cytokine (Liu et al., 2004; Rogers et al.,
2000).When exposed to infection, memory T cells secrete IFNγwithin
minutes. We utilized an in-vivo method to detect T cells that make
IFNγ after infection (Foster et al., 2007; Liu and Whitton, 2005;
Whitmire et al., 2008b). The method involves infecting mice and then
treating them with Brefeldin-A to force reactive T cells to sequester
cytokine intracellularly. Splenocytes are harvested and immediately
surface stained to identify virus-speciﬁc cells and stained for
intracellular levels of IFNγ. Using this assay, we compared naïve and
memory T cells in the same host and found that memory cells respond
to infection by producing IFNγ by 6–12 h after infection; naïve T cells
in the same conditions did not make detectable levels of IFNγ.
(Whitmire et al., 2008b) These data show that memory cells are
geared to respond quickly to infection by producing antiviral cytokine.
The IFNγ locus is epigenetically modiﬁed in memory cells compared
to naïve cells (Kersh et al., 2006; Northrop et al., 2006); the histones at
this locus are demethylated, thus making the local heterochromatin
open and accessible to transcription factors. These data resemblewhat
is found for memory CD8+ T cells: virus-speciﬁc CD8+ T cells in
immune mice kill target cells within minutes (Barber et al., 2003;
Yates et al., 2007). Hence, a quiescent population of CD8+ memory
cells can defend very quickly and during the same periods usually
associated only with the innate immune system—thus, memory T cells
exert their effects long before their accumulation appears.
Cytokine patterns
As responding T cells differentiate, they increase their ability to
produce IFNγ, TNF, and IL-2. It is not clear why there is a difference in
kinetics between IFNγ production and IL-2 secretion, but it may relate
to the antiviral activity of IFNγ, which is needed immediately. The
ability to make these cytokines appears to be sequential: early on
many cells make IFNγ but not IL-2, but by the peak of the response,
most effector cells make all three cytokines. The early production of
IFNγ and TNF serves to diminish virus infection and activate
macrophages and dendritic cells. IFNγ production by responding
T cells may be directly linked to their enhanced expansion (see
below). Early production of IL-2 could be detrimental to expanding
effector cells if its impact on NK cells or Treg cells is greater than that
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of T cells, may correspond with the transition of effector cells into the
memory phase: IL-2 given during the contraction protects antiviral
CD8+ and CD4+ T cells from apoptosis and increases memory. The
expedited production of IL-2 by memory T cells may play a role in
accelerating their accumulation once cell-division commences.
Interferons simultaneously suppress virus replication in target cells
and stimulate antiviral T cells that ward off further infection
Numerous viruses encode proteins that either prevent the
induction of IFN or block signaling cascades that result from IFN
signals. RNA viruses are usually capped to prevent recognition by PRRs
and induction of interferon; additionally, members of the picornavirus
family (CVB, poliovirus, HAV) prevent encode proteins that block parts
of the interferon induction process or block interferon-receptor
signals. Other RNA viruses, such as members of the ﬂavivirus produce
non-structural proteins that prevent type1 IFN induction aswell as IFN
signaling. Vaccinia virus encodes decoy receptors for both type 1 and
type 2 interferons. The elaborate mechanisms that viruses use to
inhibit IFN highlight the key role of these pathways in immune
defense.
Numerous pathways are involved in the inﬂammatory response and
result in signals that act directly on T cells. For example, PRRs (NLR, TLR)
are involved in initiating the response and lead to IFNαβ production by
the infected cell, which may act directly on responding T cells and
impact their functions or accumulation. Also, early IFNγ production by
NK cells and responding T cells acts upon the IFNγR, which leads to
JAK1/2 recruitment followed by STAT1 phosphorylation by JAK1. The
STAT1-PO4 forms homodimers that travel to the nucleus and bind to
promoter elements called Gamma Activated Sequences, which are near
hundreds of genes that are upregulated as a consequence of IFNγR
signaling. IFN functions immediately during infection, but the long-term
consequence of IFN signaling is the stimulation largenumbers of effector
and memory T cells. The expansion of the CD4+ T cell population
depends on several critical pathways,which likely inﬂuences the timing
and magnitude of T cell responses. Sequential waves of interferons and
costimulatory molecules are expressed after infection, and these
interactions may result in distinct effects on T cell differentiation that
varies with time (Bertram et al., 2002).
We have shown that T cells need direct IFNγ signals to fully expand,
and they compete for this cytokine as they differentiate into effectors
andmemory cells (Whitmire et al., 2005a,b, 2007, 2008a). The receptor
for IFNγ, CD119, is expressed ubiquitously; however, the surface level of
expression increases selectively on responding virus-speciﬁc T cells,
consistent with the notion that IFN signals directly into T cells and
enhances their ability to respond. To better understand the role of direct
IFN signals in virus-speciﬁc T cell differentiation, we compared in the
samehost T cells thatwere genetically deﬁcient inγR-expressionwith T
cells that express γR (Whitmire et al., 2005a,b, 2007, 2008a). Under
these conditions, the T cells – which are identical in their speciﬁcity –
were transferred into the same WT host, where they were exposed to
the same antigen load and duration.We found that after infection, γR−
T cells expanded to lower numbers compared to the T cells that
expressed γR, despite being present at equal numbers before infection.
Similar results were seen when comparing γR+ versus γR− TCR-
transgenic T cells orwhen endogenous virus-speciﬁc T cells romγR+or
γR−micewere compared in the samehost. Ourﬁndings closely parallel
those reported for IFNαβ signals, where T cells that are sensitive to
IFNαβ expand in numbermore vigorously than do T cells that areαβR-
deﬁcient (Havenar-Daughton et al., 2006; Kolumam et al., 2005), and
we conﬁrmed this observation (unpublished data). The ﬁndings with
αβR-deﬁcient T cells are consistentwith the evidence that TLRsenhance
T cell memory; TLR signals alter APC antigen presentation capacity and
stimulate IFNαβ production from them, which acts directly on
responding T cells. Thus, IFNs act on target cells to diminish virusreplication and act on responding virus-speciﬁc T cells to augment their
accumulation.
Some reports indicate that IFNs are detrimental to T cell memory
formation or that there is no impact on memory cell formation
(Badovinac et al., 2004; Dalton et al., 2000; Haring and Harty, 2006;
Tewari et al., 2007). The varied conclusions likely stem from differences
in the methods and model systems. For example, analyses comparing T
cellmemory in separateWTand IFN-deﬁcientmice is problematicwhen
the pathogen load and duration differs. A similar concern holds when a
large proportion of APCs or other cell-types (T-reg cells, etc.) are IFNγR-
deﬁcient, as in a bone-marrow chimera. It is important to consider that
the role of IFN likely varies depending on the pathogen: virus infections
typically stimulate large amounts of IFN, but bacterial infections
stimulate an entirely different set of cytokines: other cytokine networks
may dominate in stimulating T cell responses after bacterial infection.
The effect of direct IFN signals appears after day 4 post-LCMV infection,
when the cells are accumulating exponentially; the role of IFN may not
be as apparent in infections or vaccinationswhere the stimulus does not
drive extensive cell division and accumulation. Hence,weak stimuli that
drive only a few fold changes in cell number may not appear to be
impacted by IFNs.
During a response, restrictive numbers of APC force T cells to
compete for antigen; under increasing amounts of competition,
smaller and smaller proportions of the cells undergo cell division.
We have shown, by varying the frequency of naïve virus-speciﬁc TCR-
transgenic T cells before infection, that an overabundance of identical T
cells is detrimental to antiviral T cell memory. Virus-speciﬁc CD8+ T
cells and other CD4+T cell responses showa similar pattern (Blair and
Lefrancois, 2007; Foulds and Shen, 2006;Hataye et al., 2006; Kedl et al.,
2000; Sarkar et al., 2007; Srinivasan et al., 2004; Troy and Shen, 2003;
Whitmire et al., 2008a; Willis et al., 2006). The negative impact on T
cell memory suggests that T cell differentiation may be linked to cell
division. As antigen becomes limiting and T cell number increases, the
competition for antigen becomes severewith time. T cell production of
IFNγ is tightly controlled by contact with antigen (Slifka et al., 1999),
so the effect of constrained amounts of antigen impacts virus-speciﬁc
T cell production of IFNγ, thus limiting direct IFNγ signaling into
T cells.
We propose a link between T cells that most efﬁciently elaborate
IFNγ secretion and receive IFNγR signals and their competitive ﬁtness
to out-expand other T cells and go on to differentiate into memory T
cells following acute virus infection (Fig. 3). IFNs in particular select
cells into the memory pool: competition between cells for limiting
amounts of IFN is a deciding factor in determining which cells survive
initial expansion and go on to populate the memory pool. It is not yet
clear whether the effect of IFNγR signals merely increases the
abundance of cells with the potential to differentiate into memory
cells or directly stimulates the memory program. However, it is
noteworthy that in the absence of direct γR signals, there is a
precipitous loss of T cell memory compared to identical cells that
express γR. In other words, the initial difference between the two
populations at the peak of the response exaggerates as the cells
differentiate into the memory phase, suggesting that there is a direct
connection between these signals and the memory program. Further
studies are required to delineate how direct IFN signals impact
memory cell formation and if the long-term effects are set early on or
actively deployed during the contraction phase.
T cells also appear to compete for limiting amounts of IL-7, IL-15, and
IL-2: when these cytokines are delivered as complexes to mice so that
they are overabundant across several days, antigen-speciﬁc T cells are
driven to tremendous number (Boymanet al., 2006a,b, 2008; Finkelman
et al., 1993; Kamimura and Bevan, 2007; Kamimura et al., 2006; Purton
et al., 2008; Rubinstein et al., 2006). Conversely,when T cells are starved
of these cytokines, there are severe reductions in the initial expansion
and memory levels. It is plausible that these cytokines factor into the
memory selection process and support translational efforts to use
Fig. 3. Selection of the ﬁttest: virus-speciﬁc CD4+ T cells compete for antigen and cytokines, selecting and enriching for high quality memory cells. Antiviral CD4+ T cells respond to
antigen and inﬂammation by undergoing cell-division, which can be incredibly rapid. As they accumulate in number, effector T cells begin to compete for access to antigen, which
constrains cell-division for cells that weakly interact with antigen. In addition, the most vigorously responding T cells produce IFNγ and receive direct IFNγ signals; the best
responders receive the greatest amount of IFNγ signaling and continue to accumulate. IFNγ signals also enhance memory cell formation. It is unclear if direct IFNγ signals activate a
program of memory cell differentiation or increase the number of memory cell precursors that have the potential to survive.
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vaccine-induced memory T cells.
There are gaps in our understanding of how other pro-inﬂammatory
pathways affect T cell memory formation. Some pathways act directly
on respondingT cells, others function indirectly throughAPCs, and some
(MyD88, IFNαβ, IFNγ) act on both. NLRs sense bacterial and some DNA
or RNA virus infections (Allen et al., 2009; Ichinohe et al., 2009; Kuenzel
et al., 2010; Lamkanﬁ andKanneganti, 2010;Neerincx et al., 2010). NLRs
induce IL-1β production, which signals directly into T cells to enhance
their expansion (Ben-Sasson et al., 2009). Consistent with this notion,
IL-1R-deﬁcient mice show deﬁcits in lung CD4+ T cell responses
following inﬂuenza infection (Schmitz et al., 2005). IL-12 and IL-18 are
made by activated dendritic cells after virus infection; T cells express
receptors for these cytokines and their differentiation into Th1 cells is
impacted by these signals (Srinivasan et al., 2007) and may affect the
expansion of CD4+ T cells and their differentiation into memory cells
(Boelen et al., 2002;Haring andHarty, 2009; Pien et al., 2000; Srinivasan
et al., 2007; Tough et al., 2001). Type-III interferons (IFN-λ) are
produced during some virus infections and are particularly abundant at
skin andmucosal sites. IFN-λ is stimulatedby someof the pathways that
induce IFNαβ; the receptor for IFN-λ is IL-28Rαβ and is expressed on a
limited number of cells, including T cells (Donnelly and Kotenko, 2010).
IFN-λ signaling into non-T cells diminishes virus replication in target
cells and results in an IFNαβ burst. The effect of IFN-λ signaling into
antiviral T cells and their ability to form memory cells remains to be
investigated. From the standpoint of improving vaccines against viruses,
it would be interesting to learn whether the quality or number of
memory cells differs when they differentiate with IFNγ signals versus
IL-1β, IFNαβ, IFN-λ, IL-12, or IL-18. DNA viruses and RNA viruses differ
in the kinds of innate pathways that are stimulated, and there may be
consequent effects on virus-speciﬁc T cell memory.
TLR ligands also act on T cells to augment their responses (Marsland
et al., 2007). MyD88 conveys signals emanating from TLRs that induce
IFN within target cells, but there may be additional functions for this
molecule. Intriguing data show that MyD88 signals within T cells
inﬂuence their accumulation after viral infections (Rahman et al., 2008;
Zhao et al., 2009; Zhou et al., 2009). Thus, additional MyD88 functions
may overlap with MyD88-mediated induction of IFN signaling to
enhance antiviral T cell responses. T cell differentiation is likely
determined by a variety of signals, including TCR strength and duration,IFN and other combinations of pro-inﬂammatory cytokines, and TLR
signaling (Nembrini et al., 2006).
Discussion
Antiviral CD4+ T cell responses begin from a small number of cells
that undergo tremendous rates of cell division and accumulate under
the positive inﬂuence of inﬂammatory cytokines. These early signals
enhance their number and further their differentiation into memory
cells. Once set, CD4 memory is maintained by homeostatic cytokines
and by B cells through unknown mechanisms. Th1 memory cells
sustain antiviral CD8 T cell responses and are involved in CD8+ T cell
recruitment to peripheral sites; other lineages of antiviral CD4+T cells
can be found after infection, but their longevity and protective role
during recall responses need to be studied.
Most studies have examined the inﬂuence of innate immune
defense on developing T cells, but in an immune individual, the
adaptive response occurs concurrently and possibly before innate
defenses. How do cytokine-secreting memory T cells affect infected
target cells, APC function, and NK cell activity? How do these signals
impact ISG functions within infected target cells, given that some
proteins (eg, MyD88) may have multiple functions? Conversely, there
is evidence that innate immunity inﬂuences effective recall responses:
in the absence of PKR – a cytoplasmic sensor of viral RNA that
stimulates IFN responses – existent memory CD8+ T cells did not
effectively eliminate a challenge virus infection (Nakayama et al.,
2010). Thus, innate detection of infection and the positive effects of
inﬂammatory cytokines on established T cell memory is an important
area for future investigation, as it relates to how best to boost
immunity with vaccination.
The role of IFNs, costimulatory molecules, and pro-inﬂammatory
cytokines during chronic virus infection could be very different from
that seen during acute infection. The immune system is hyper-activated
during HIV infection, such continuous stimulation may induce an
endogenous program that downregulates adaptive immunity under
these circumstances. During chronic virus infection, virus-speciﬁc T cells
are either deleted or become dysfunctional over time (Brooks et al.,
2005; Fuller et al., 2004, 2005; Fuller and Zajac, 2003;Mothe et al., 2007;
Zajac et al., 1998a,b). Antiviral CD4+ T cells become non-functional like
CD8+ T cells. The molecular mechanisms underlying these effects are
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2006; Bengsch et al., 2010; Blackburn et al., 2009; Freeman et al., 2006;
Grosso et al., 2009; Wherry et al., 2007), CD27-CD70 (van Gisbergen et
al., 2009), CTLA4-B7, Lag3 (Bengsch et al., 2010; Blackburn et al., 2009),
and IL10-IL10R (Brooks et al., 2006a,b, 2008; Ejrnaes et al., 2006)
interactions inhibit reactive cells during chronic infection inmice and in
people. During chronic virus infection, reactive T cells may produce
IFNγ – possibly lower amounts than seen during acute infection – and
the expression of this cytokine might have inhibitory effects during
chronic infection: IFNγ induces PD1L on APCs (Muhlbauer et al., 2006;
Schreiner et al., 2004), and IFNγ acts on Treg cells to increase their
inhibitory activity. Data in other models indicate that IFNγ signals into
non-T cells inhibit memory T cell formation (Sercan et al., 2006, 2010).
While the amount and duration of antigen can enhance CD4 T cell
responses following acute infection, recent evidence shows that
extensive persistence of large amounts of antigen can be detrimental
to CD4+ T cell responses (Han et al., 2010), and CD4+ T cells that are
removed from such an environment can recover their ability to produce
cytokine. Treating chronically infected mice with ribavirin results in a
reduction in virus load, and exhausted CD4+ T cells recover some of
their functions (Brooks et al., 2006a). Thus, chronic virus infection may
diminish CD4+ T cells by induction of immunosuppressive cytokines
and inhibitory cell-surface molecules, or by simply over-stimulating
them. Future studies need to clarify the roles of type 1 and type 2 IFN on
antiviral T cell responses throughout chronic virus infection. Interest-
ingly, persistent LCMV infection of mice does not result in persistently
elevated levels of IFNαβ, suggesting that there are othermechanisms at
play that diminish innate immune responses—perhaps the inhibited
production of IFNαβ is related to the development of exhausted T cells.
The magnitude of the primary and recall CD4+ T cell response is
governed by antigen load and pro-inﬂammatory cytokines, and the two
factors are linked: the antigen load inﬂuences howmuch IFNγ ismade by
respondingT cells and theextent towhich they receivedirect IFNγ signals.
The principal mechanism for priming antiviral CD4+ T cells is through
endocytic processes that take-up extracellular protein, degrade it, and
load the resulting peptides onto MHCII molecules. However, other
mechanisms, including macroautophagy, result in the presentation of
peptides from cytosolic proteins (Deretic, 2009; Gannage and Munz,
2009; Lee and Iwasaki, 2008; Munz, 2006, 2007). CD4+ T cell responses
form against HSV and EBV (nuclear antigen 1 EBNA1) proteins that are in
the cytoplasm of MHCII+ cells. Certain proteins that have escaped
ubiquitin-mediated proteasomal degradation can be captured by auto-
phagosomes and transported to lysosomes. These tend to be long-lived
proteins and also ones that form large aggregates, which become
encapsulated in autophagosomes that fuse with lysosomes, where the
proteins are degraded and loaded onto resident MHCII molecules. In
addition tomacroautophagy, chaperone-mediated autophagy– the active
heat-shock protein mediated transport of proteins directly into the
lysosome– results inproteolyticdegradationofproteins intopeptides that
bind toMHCII molecules. Virus proteins aggregate to form structures that
efﬁcientlypackage their genomes,whichmay induce the autophagosomal
process and lead to peptides that are recognized by CD4+ T cells. The
extent to which macroautophagy contributes to the overall CD4+ T cell
response after virus infection remains to be quantiﬁed and compared to
the well-established exogenous pathway. Type 1 and Type 2 interferons
increase the amount of autophagy within cells, which may enhance the
amount of antigen is presented to CD4+ T cells and affect themagnitude
of the response. There may also be differences in how proteins are
degraded in the late endosome/lysosome pathway versus the autophago-
some/lysosome pathway, potentially determining the populations of
virus-speciﬁc CD4+ T cells that respond. Lysosomes that have fusedwith
autophagosomes may contain different sets of molecules compared to
lysosomes that fuse with phagosomes; the co-expression of these other
molecules with MHCII molecules on the surface of cells might also
inﬂuence the developing CD4+ T cell response. Many viruses encode
proteins that prevent MHC presentation; this may impact CD4+ T cellresponses that depend upon autophagosome-mediated antigen presen-
tation in the same infected cell but not affect CD4+ T cells that recognize
antigenproduced in the classical phagocytic processor receptor-mediated
uptake in non-infected cells. It is unclear what proportion of CD4+T cells
respond to material derived from extracellular protein versus macro-
autophagy, andhow these pathways differ in T cell-dependent protection.
The genomics of antiviral immunity
Nearly all analyses of immune response to vaccination or infection
are done in highly inbred mouse models. Pre-clinical studies to
evaluate vaccines typically begin with studies in standard inbred
mouse models. General response patterns in mice will mimic those in
people, but there are exceptions, which need to be studied. Mouse
models are useful, because many tools are available to quantify
immune responses, which is essential for understanding the under-
lying processes involved in resolving infection and establishing T cell
memory. However, there are several problems with existing mouse
models: much of the immune response is dominated by a few genes,
different inbred mouse strains have lost some of these genes, and
mice vary in their expression of the these genes, whichmay notmatch
with normal expression patterns. Additionally, many inferences about
certain pathways are based on data from gene-ablated mice—such
experimental approaches are straightforward and easy to interpret,
but rarely do people have absolute deﬁciencies in those particular
genes. Normal individuals vary in alleles of genes and in the amount of
expression of those genes, and they differ in non-coding regions of the
genome. Critical variation beyond allelic variances at the MHC locus
includes differences in intrinsic antiviral pathways and PRRs,
including the induction of interferons that amplify differences in
subsequent T cell responses. All of these differences with intact genes
impact phenotypes seen in people—such natural variation is not
replicated in inbred strains of mice. A robust outbred mouse model
that factors in the natural variations in components of these networks
may better predict which pathways are critical for immunity
(Churchill et al., 2004; Yalcin et al., 2010). The quantitative analysis
of immune responses following infection or vaccination in outbred
populations of mice followed by quantitative associations with certain
genetic loci associated with inﬂammation will play a key role in the
future for dissecting how to best develop protective immune
responses with vaccines.
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